Tension headaches and muscle tension: Is there a role for magnesium?

Medical Hypotheses

Volumn 57, Issue 6, 2001, Pages 705-713

  Altura, B M ^a   Altura, B T ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM ION; MAGNESIUM SALT;

ADULT; ARTICLE; CASE REPORT; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; FEMALE; HUMAN; HYPOTHESIS; MAGNESIUM METABOLISM; MEDIATOR RELEASE; MUSCLE CRAMP; MUSCLE TONE; PRIORITY JOURNAL; TENSION HEADACHE;

EID: 0035666336     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1439     Document Type: Article

References (90)

1. Cluster headache: Horton's cephalalgia revisited
2. The treatment of tension type headache
3. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain
4. Tension headaches: Psychophysiological investigation and treatment
5. Is the muscular model of headache still viable? A review of conflicting data
6. Muscular disorders in tension-type headache
7. Mental stress of long duration: EMG activity, perceived tension, fatigue, and pain development in pain-free subjects
8. Tension headache: Botulism toxin paralysis of temporal muscles
9. Pericranial tenderness in tension headache. A blind, controlled study
10. Muscular disorders in tension-type headache
11. Ketoprofen, acetaminophen and placebo in the treatment of tension headache
12. Treatment of chronic tension headache
13. The use of antidepressants in the treatment of chronic pain. A review of the current evidence
14. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies
15. Antidepressant treatment of chronic tension-type headache: A comparison between fluoxetine and desipramine
16. Is chronic tension-type headache a vascular headache? The relation between chronic tension-type headache and cranial hemodynamics
17. Cardiovascular sympathetic hypofunction in muscle contraction headache and migraine
18. Plasma monoamines in tension-type headache
19. Inflammatory alterations in muscle contraction headache
20. Orbital phlebography: A comparison between cluster headache and other headaches
21. The role of magnesium in etiology of strokes and cerebrovasospasm
22. Migräne-magnesium
23. Calcium antagonist properties of magnesium: Implications for antimigraine actions
24. Low brain magnesium in migraine
25. Mitochondria, magnesium and migraine
26. 31 magnetic resonance spectroscopy interictal study
27. Serum and salivary magnesium levels in migraine and tension-type headaches. Results in a group of adult patients
28. Migraine treatment by oral magnesium intake and correction of the irritation of buccofacial and cervical muscles as a side effect of mandibular imbalance
29. Serum and red blood cell magnesium levels in juvenile migraine patients
30. Electromyographical ischemic test, and intracellular and extracellular magnesium concentration in migraine and tension-type headache patients
31. Magnesium content of mononuclear blood cells in migraine patients
32. 2+ ratio
33. Serum ionized magnesium levels in patients with tension-type headaches
34. Chronic daily headache-one disease or two? Diagnostic role of serum ionized magnesium
35. Serum ionized magnesium levels in patients with episodic and chronic cluster headaches
36. 2+ ratios in patients with episodic and chronic cluster headaches
37. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum magnesium levels
38. Intravenous magnesium sulfate relieves migraine attacks in patients with low serum ionized magnesium levels: A pilot study
39. Serum ionized magnesium levels in 500 patients with headaches
40. Intravenous magnesium sulfate rapidly alleviates headaches of various types
41. Serum ionized magnesium as a biological marker in patients with headaches
42. Intravenous magnesium sulfate aborts headache attacks in patients with low serum ionized magnesium levels
43. Magnesium for migraine. Rationale for use and therapeutic potential
44. Role of magnesium in the pathogenesis and treatment of migraines
45. Platelet ionized magnesium, cyclic AMP and cyclic GMP levels in migraine and tension-type headaches
46. Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium
47. Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study
48. The effect of magnesium on the responsiveness of migrainers to a 5-HT-1 agonist
49. The neurobiology of vascular head pain
50. The role of nitric oxide in migraine pain: Therapeutic implications
51. Pathobiology of magnesium deficiency; a cytokine/neurogenic inflammation hypothesis
52. Endothelium-dependent relaxation in coronary arteries requires magnesium ions
53. The platelet and migraine
54. Magnesium inhibits platelet activity: An in-vitro study
55. Serum ionized magnesium deficiency is common in women with mentsrual migraines
56. Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women
57. Serum ionized magnesium and calcium in women after menopause: Inverse relationship of estrogen with ionized magnesium
58. Predictive value of serum ionized but not total magnesium levels in head injuries
59. Alcohol-associated acute head trauma in human subjects is associated with early deficits in serum ionized Mg and Ca
60. Withdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries
61. 2+ versus organic calcium channel blockers on myogenic tone and agonist-induced responsiveness of blood vessels
62. 31-NMR spectroscopy and a unique ion-selective electrode
63. Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease
64. Magnesium deficiency-induced spasms of umbilical vessels: Relation to preeclampsia, hypertension, growth retardation
65. Low levels of serum ionized magnesium found in stroke patients result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells
66. Neurobiology. Taking apart NMDA receptors
67. Role of excitatory amino acids in regulation of rat pial microvasculature
68. 2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions
69. 31-NMR
70. Type A behavior and coronary vasospasm: A possible role of hypomagnesemia
71. Is Type-A behavior modulated by genetic factors regulating magnesium and zinc metabolism? Working hypothesis and preliminary results
72. Correlation of A/B behavior pattern, alcohol intake, HDL-cholesterol and serum magnesium levels in middle-aged men
73. Metabolic factors in peripheral circulatory regulation
74. Relationships between blood magnesium changes and physical performance
75. Protective effect of some organic magnesium compounds upon muscular cramps in swimmers
76. Restless leg syndrome
77. Nocturnal myoclonus and restless legs syndrome
78. Nocturnal paryxysmal dystonia
79. Parasomnias (non-epileptic nocturnal episodic manifestations) in patients with magnesium deficiency
80. Clinical, EEG, electromyographic and polysomnographical studies in restless legs syndrome caused by magnesium deficiency
81. Is magnesium a limiting factor in competitive exercise? A summary of relevant scientific data
82. Clinical haematological and neurophysical evidence of muscle damage from magnesium deficiency in athletes: A case report
83. Magnesium and physical activity
84. The effects of a supplementation with magnesium alone, or in combination with iron in 9 athletes (medium-distance runners)
85. Protective effect of magnesium on release of proteins from muscle during a marathon run